Methods of preparation of bioginkgo

Details Methods of preparation of bioginkgo Methods of preparation of bioginkgo

1998-11-23

2001-01-16

Tate, Christopher (Department: 1651)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

C514S027000

Reexamination Certificate

active

06174531

ABSTRACT:

FIELD OF THE INVENTION
The present invention encompasses a novel process for producing extracts of
Ginkgo biloba
leaves. The invention particularly relates to a process leading to new chemical compositions useful for therapeutic purposes. More particularly, the invention relates to
Ginkgo biloba
extracts containing an increased concentration of a major endogenous lactone normally found in such leaves and shows improved biological activity. Further, the processes of the invention allow for control over the ratio of flavone glycosides to lactones in the final composition.
BACKGROUND OF THE INVENTION
Ginkgo biloba
is one of the oldest species in the world, and is considered a living fossil. Zhongliang, Chin. Pharm J. 1996, 31:(6) 326-331. It is indigenous to China, although now it has been introduced and cultured in most places in the world. The mature seeds are edible and are used as one of the traditional Chinese medicines. The chemical constituents of Ginkgo leaves are characterized by the presence of diterpene (sesquiterpene) lactones, and flavonoid glycosides as active principles, and ginkgolic acids as toxic substances in the
Ginkgo biloba
extract (GBE). Some of the above mentioned compounds are used as reference substances in qualitative and quantitative analysis of GBE. Ginkgolides A, B, C are diterpene lactones; bilobalide is a sesquiterpene lactone. The lactones are specific antagonists against platelet activating factors (PAF). Flavonoid glycosides are thought to have many useful biological activities including the activities of dilating coronary vessels, improving peripheral and brain blood circulation, and preventing intravascular thrombogenesis. For example, extracts from the leaves of the
Ginkgo biloba
tree (maidenhair tree) have been used for many years in the treatment of patients with conditions related to aging (DeFeudis, F. G., (1991)
Ginkgo biloba
extract. (EGb 761): Pharmacological activities and clinical applications. Editions Scientifiques Elsevier, Paris; Kleijnen, J., Knipschild, P. (1992) Lancet 340, 1136-1139). These conditions include cerebral insufficiency, which is defined by a group of symptoms exemplified by problems with short-term memory and concentration, lack of energy, tinnitis, headache, and depression (Kleijnen, J., Knipschild, P. (1992)
Br. J. Clin. Pharmacol
. 352-358). The most important active ingredients of the extracts are thought to be the flavonoids and the terpenoids, whereas ginkgolic acids are believed to cause contact dermatitis and other toxicities.
Ginkgo extracts are usually standardized in terms of their flavonoid glycoside and terpene lactone (ginkgolides and bilobalide) content (Sticher, O. (1993)
Planta Med
., 59, 2-11; Stinke, B., Muller, B., Wagner, H. (1993)
Planta Med
. 59, 155-160). Methods of preparing active extracts of
Ginkgo biloba
have been described in the art.
U.S. Pat. No. 5,637,302 is directed to a process where the lipophilic substances are removed from the extracts of
Ginkgo biloba
leaves using n-hexane, n-heptane or a solvent comprising a major proportion of toluene and a minor proportion of n-butanol. The resultant compositions (extracts) are disclosed as containing 22-26% flavone glycosides and 2.5-4.5 weight percent each of ginkgolides and bilobalide.
U.S. Pat. No. 5,512,286 is directed to extracts of
Ginkgo biloba
free of serum precipitating and/or hemagglutinating properties. The leaves are extracted using an aqueous acetone or alkanol (with 1-3 carbon atoms) or anhydrous methanol, precipitating out the lipophilic components, adding ammonium sulfate and extracting with methyl ethyl ketone, a multi-step extraction with water-immiscible butanol or pentanol (or, alternatively, with lead salts), alcohol extractions and column chromatography using a polyamide, or preferably a cross-linked polyvinyl pyrrolidone substitute.
Similarly, U.S. Pat. No. 5,399,348 describes extracts of
Ginkgo biloba
where the leaves are extracted using an aqueous acetone or alkanol (with 1-3 carbon atoms) or anhydrous methanol, precipitating out the lipophilic components, adding ammonium sulfate and extracting with methyl ethyl ketone, diluting in an aqueous alcohol solution which is treated with a lead salt or insoluble polyamide and extracting with an aliphatic or cycloaliphatic solvent.
EP-A 0 324 197 describes a method for the preparation of an extract from
Ginkgo biloba
leaves in which an aqueous solution of a lower alcohol or ketone, obtained after extraction of the leaves, is concentrated in the presence of kieselguhr. The resultant aqueous suspension is filtered through kieselguhr, the filtrate is extracted with butanone and the extract is freed from the solvent.
EP-A 330 567 relates to a method for the preparation of an extract from
Ginkgo biloba
leaves in which the crushed leaves are extracted with an aqueous ketone compound. This extract is concentrated until biflavones and hydrophobic compounds precipitate. After filtration the aqueous concentrate is rendered alkaline, whereby the proanthocyanidins precipitate. After separation of the precipitate and acidification of the filtrate, a liquid-liquid-extraction is carried out with a C
4-6
-ketone compound in the presence of ammonium sulfate. The extract is obtained after stripping of the ketone compound.
The extracts from
Ginkgo biloba
leaves prepared by the methods in DE-B 17 67 098 and DE-B 21 17 429 are disclosed as being substantially free of alkylphenol compounds due to removal of the lipophilic components by a liquid-liquid extraction of the aqueous acetone extract with a substantially water-immiscible lipophilic solvent, e.g. with a chlorinated aliphatic lower hydrocarbon such as carbon tetrachloride. However, while the content of flavone glycosides is increased from 3 to 4% in the crude extract to approximately 24% in the final product, in this step, the therapeutically valuable ginkgolides and the bilobalide are considerably reduced so that their content in the final product in Example 1 of DE-B 21 17 429 is a maximum of 0.5% in the case of ginkgolides A, B, C, and J in total and approximately 0.3% in the case of bilobalide. Also, chlorinated aliphatic hydrocarbons are associated with certain toxicities and are generally undesirable.
U.S. Pat. No. 5,399,370 is directed to extracts of
Ginkgo biloba
having 40-60% flavone glycosides, 5.5-8.0% ginkgolides and 0.5-7.0% bilobalides. The method involves extraction with either aqueous alkanol or acetone or anhydrous methanol, precipitating out the lipophilic components, extracting with an ester of formic acid or acetic acid, and an additional extraction with a butanol or pentanol. Activated carbon may also be used to remove certain substances prior to the ethyl acetate or ester extraction.
The Ginkgo extract used most frequently at present for therapeutic purposes (tanakan
R
; roekan
R
or tebonin
R
; “EGb 761”) contains, besides 24% flavone glycoside compounds, 6% terpene lactone compounds; see K. Drieu,
La Presse Medicale
Vol. 15 (1986), 1455-1457. These are the ginkgolides A, B, C and J as well as the bilobalide, which makes up approximately half of the 6%. The content of ginkgolide B found in currently available preparations ranges from about 0.88% to about 1.3%. The therapeutic daily dosage is 120 mg.
EP-A-86 315 describes a method of reducing the content of polymeric polyphenol compounds in the extracts by means of polyvinyl pyrrolidone in ethanolic-aqueous solution.
U.S. Pat. No. 4,981,688 discloses a method for extraction of
Ginkgo biloba
involving extraction from the leaves using an aqueous ketone solvent; concentration of the extraction liquors in order to precipitate the biflavonoids and the hydrophobic substances; alkalinization of the filtrate so as to precipitate the proanthocyanidins; acidification of the filtrate; liquid-liquid extraction of the filtrate with a C
4
-C
6
ketone in the presence of ammonium sulfate; and recovery of the extract by taking the ketone phase to dryness.
Flavones have also been extracted from
Ginkgo biloba
leaves with boiling water and an abso

Affiliated with

Also associated with

Rating

Methods of preparation of bioginkgo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of preparation of bioginkgo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of preparation of bioginkgo will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2487142